Volume 150, Issue 4
Original Article
Free Access

A real‐time digital bio‐imaging system to quantify cellular cytotoxicity as an alternative to the standard chromium‐51 release assay

Julien Fassy

Université Côte d'Azur, CNRS UMR7275, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France

The authors contributed equally to the work.Search for more papers by this author
Kyriaki Tsalkitzi

Université Côte d'Azur, CNRS UMR7275, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France

The authors contributed equally to the work.Search for more papers by this author
Emie Salavagione

Université Côte d'Azur, CNRS UMR7275, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France

Search for more papers by this author
Nedra Hamouda‐Tekaya

Université Côte d'Azur, CNRS UMR7275, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France

Search for more papers by this author
Véronique M. Braud

Corresponding Author

E-mail address: braud@ipmc.cnrs.fr

Université Côte d'Azur, CNRS UMR7275, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France

Correspondence: Dr Véronique Braud, Institut de Pharmacologie Moléculaire et Cellulaire, CNRS/UNS UMR7275, 660, route des Lucioles, Valbonne 06560, France. Email: braud@ipmc.cnrs.fr

Senior author: Véronique M. Braud

Search for more papers by this author
First published: 22 December 2016
Citations: 2

Summary

Reliable measurement of cellular cytotoxicity is essential for the characterization of immune responses and for the monitoring of antibody treatment efficacy. Until now, the standard 51Cr‐release assay has remained the sole sensitive assay that measures cellular cytotoxicity. Alternative non‐radioactive assays have been developed but they do not provide accurate measurement of target cell cytotoxicity. The cost and hazard of handling radioactivity are strong incentives to find alternative solutions to 51Cr. We took advantage of the recent development of cell‐imaging multimode readers to develop a novel non‐radioactive and real‐time cytotoxic assay that demonstrates good reproducibility and sensitivity. The extent of target‐cell cytotoxicity is monitored over time by imaging and quantifying live fluorescent target cells in 96‐well plates. We have developed classical natural killer cell assays in the presence or absence of blocking antibodies and antibody‐dependent cell‐mediated cytotoxicity. We show that in these assays, cell killing occurs within the first 2 hr with half maximum killing reached after 30 min. This technology has numerous applications such as natural killer and T‐cell cytotoxicity assays and can be extended to cell survival and apoptosis measurement assays.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.